Precision BioSciences' charter amendment for officer exculpation fails at annual meeting

PRECISION BIOSCIENCES INC

Kevin J. Buehler and Shari Lisa Piré elected as Class III directors.
Deloitte & Touche ratified as auditor (7,445,447 FOR, 12,604 against).
Advisory say-on-pay approved; board sets frequency at every 1 year.
Proposal for officer exculpation amendment failed: ~3.5M FOR votes (95% of cast) but not >50% of outstanding shares, largely due to 3.75M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.